Dissect formative pluripotency using cultured pluripotent stem cells

使用培养的多能干细胞剖析形成性多能性

基本信息

  • 批准号:
    10621933
  • 负责人:
  • 金额:
    $ 34.06万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-07-22 至 2026-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Derivation of pluripotent stem cells (PSCs) has revolutionized developmental biology and regenerative medicine. To stably maintain PSCs in culture and guide them to differentiate with high efficiency and fidelity into a variety of cell types, it is important to understand the molecular mechanisms governing pluripotency (the ability of a cell to generate any tissues in the body). Two phases of pluripotency, naïve and primed, have been defined and studied in detail thanks to the successful derivation of mouse embryonic stem cells (ESCs) and epiblast stem cells (EpiSCs), respectively. Mouse ESCs most closely resemble epiblast from a 4-day-old mouse blastocyst (~embryonic day 4, or E4), while “primed” EpiSCs display a global gene expression signature similar to the E7 epiblast of a post-implantation mouse embryo. Despite these advances, however, however, there is lack of a well-established PSC model that resembles E5-6 early post-implantation epiblast, which corresponds to the formative phase of pluripotency. Formative pluripotency exists within a time window during which naïve pluripotency is reconfigured to prepare for multilineage competency, including germ cells. Functionally, formative pluripotency is characterized by both chimera competency and permissiveness for direct primordial germ cell (PGC) induction. Several recent studies have attempted to define this state by transient epiblast-like cells (EpiLCs) differentiated from ESCs. To date, however, stable formative PSCs have not yet been generated. By modulating the FGF, TGF-β and WNT pathways, we recently derived PSCs from both mice and humans (referred to as FTW-PSCs) that are permissive for direct PGC-like cell induction in vitro and are capable of contributing to intra- or inter-species chimeras in vivo. FTW-PSCs harbor molecular, cellular and phenotypic features characteristic of formative pluripotency. The overall objective of this proposal is to use these newly established cell lines to comprehensively dissect the formative state across species. The proposed studies will elucidate the roles of several transcription factors in regulating mouse and human formative pluripotency, as well as demonstrate that FTW-PSCs are a robust platform for dissecting the molecular mechanisms underlying human and mouse PGC specification. In addition, we will establish an in vitro platform for the generation of functional mouse oocytes and human oogonia based on formative FTW-PSCs, thereby providing an invaluable resource for studying germ cell development and human infertility. Our proposal has tremendous potential to revolutionize regenerative medicine and reproductive biology.
项目总结/文摘

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Self-organization of vascularized skeletal muscle from bovine embryonic stem cells.
来自牛胚胎干细胞的血管化骨骼肌的自组织。
  • DOI:
    10.1101/2024.03.22.586252
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Sanaki-Matsumiya,Marina;Villava,Casandra;Rappez,Luca;Haase,Kristina;Wu,Jun;Ebisuya,Miki
  • 通讯作者:
    Ebisuya,Miki
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jun Wu其他文献

Jun Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jun Wu', 18)}}的其他基金

Dissect the mechanisms underlying interspecies pluripotent stem cell competition
剖析种间多能干细胞竞争的机制
  • 批准号:
    10576347
  • 财政年份:
    2022
  • 资助金额:
    $ 34.06万
  • 项目类别:
Dissect the mechanisms underlying interspecies pluripotent stem cell competition
剖析种间多能干细胞竞争的机制
  • 批准号:
    10364140
  • 财政年份:
    2022
  • 资助金额:
    $ 34.06万
  • 项目类别:
Dissect formative pluripotency using cultured pluripotent stem cells
使用培养的多能干细胞剖析形成性多能性
  • 批准号:
    10455585
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
Dissect formative pluripotency using cultured pluripotent stem cells
使用培养的多能干细胞剖析形成性多能性
  • 批准号:
    10297495
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
酒精性肝病(NIAAA)中的新型胆碱能回路
  • 批准号:
    10371184
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
酒精性肝病(NIAAA)中的新型胆碱能回路
  • 批准号:
    10559556
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
A novel cholinergic circuitry in alcoholic liver disease (NIAAA)
酒精性肝病(NIAAA)中的新型胆碱能回路
  • 批准号:
    10092344
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
Derivation of chimera competent pig embryonic stem cells under a novel condition
在新条件下衍生嵌合体感受态猪胚胎干细胞
  • 批准号:
    10205187
  • 财政年份:
    2020
  • 资助金额:
    $ 34.06万
  • 项目类别:
The role of immune-adipocyte cholinergic signaling during metabolic adaptation and dysfunction
免疫脂肪细胞胆碱能信号在代谢适应和功能障碍中的作用
  • 批准号:
    10570872
  • 财政年份:
    2016
  • 资助金额:
    $ 34.06万
  • 项目类别:
The role of immune-adipocyte cholinergic signaling during metabolic adaptation and dysfunction
免疫脂肪细胞胆碱能信号在代谢适应和功能障碍中的作用
  • 批准号:
    10202938
  • 财政年份:
    2016
  • 资助金额:
    $ 34.06万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 34.06万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 34.06万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 34.06万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了